Arc Medical Devices Inc

Call
Website
2386 East Mall
Vancouver, BC V6T 1Z3
+1 (604) 222-9577
https://arcmedinc.com

ARC Medical Devices Inc, based in Vancouver, BC, is a clinical-stage company dedicated to transforming the prevention of surgical adhesions through innovative solutions. Their flagship product, a liquid therapeutic known as JOCOAT, offers complete intraperitoneal coverage and is designed to enhance patient recovery following surgical procedures.

Committed to combining science and design, ARC Medical focuses on creating user-friendly and effective medical devices that address significant unmet medical needs in the surgical field. With a vision to positively impact health outcomes, the company seeks partnerships to expand the reach of its groundbreaking technology in the billion-dollar market for adhesion prevention.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs and drug proprietaries, Biological research

Xylon Biotechnologies Ltd

Xylon Biotechnologies Ltd is a leading biotech company based in Vancouver, BC, specializing in cutting-edge research and development in the field of biotechnology. The company is dedicated to providing innovative solutions and advancements in various topics related to biotechnology, setting the standard for excellence in the industry. Generated from the website
Drugs and drug proprietaries

Immgenics Pharmaceuticals Inc

Immgenics Pharmaceuticals Inc is a biotechnology company based in Vancouver, BC, specializing in research and development of innovative medical treatments. With a focus on cutting-edge technologies and scientific advancements, the company is dedicated to improving healthcare outcomes and addressing unmet medical needs through its pharmaceutical products. Generated from their business information
Drugs and drug proprietaries

Achieve Life Sciences Inc

Achieve Life Sciences, Inc. is a specialty pharmaceutical company based in Vancouver, BC, focused on addressing the global nicotine dependence epidemic through the advancement of cytisinicline. Currently in the late stages of development, the company submitted a New Drug Application to the FDA in June 2025 for cytisinicline as a treatment for smoking cessation in adults. Cytisinicline has shown promise in clinical trials, demonstrating favorable odds of helping even highly dependent smokers quit, while potentially having fewer side effects compared to existing treatments. With nicotine dependence affecting millions and contributing to substantial healthcare costs, Achieve Life Sciences aims to redefine treatment options for this widespread public health crisis. Generated from the website
Canada›British Columbia›Vancouver›Arc Medical Devices Inc

Partial Data by Infogroup (c) 2025. All rights reserved.